resTORbio Inc (NASDAQ:TORC)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - TORC

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - TORC

  • Market Cap$86.400m
  • SymbolNASDAQ:TORC
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS76133L1035

Company Profile

resTORbio Inc is a clinical-stage biopharmaceutical company. It mainly focuses on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. The company focuses on the mechanistic target of rapamycin (mTOR) pathway which regulates aging, and specifically on selective inhibition of the target of rapamycin complex 1. It is also involved in the development of RTB101 which is a small molecule, potent TORC1 inhibitor. The company's pipeline products include RTB101 and RTB101+ everolimus.resTORbio Inc is a clinical-stage bio-pharmaceutical company. It is engaged in the development and commercialization of novel therapeutics for the treatment of aging-related diseases.

Latest TORC news

Currently there for this company. Visit our news hub for other news .